Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering developing manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980 Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Red biotechnology refers to pharmaceutical, medicinal and diagnostic applications of biotechnology. Typical red biotech company products include vaccines, therapeutics, diagnosis kit, cell therapy, and the like. Red biotechnology stakeholders are playing a vital role in increasing the quality and length of human health. Encoded by BioDirecta Database as RED.